The FGFR3-TACC3 fusion is a common alteration in various cancers [33], including glioblastoma multiforme [34], NSCLC [35], cervical cancer [36], and triple negative breast cancer [37]. This evidence concerns the gene TACC3 and non-small cell lung carcinoma.